DELTA-FLY PHARMA, INC.
Patent Owner
Stats
- 9 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- Jan 02, 2018 most recent publication
Details
- 9 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 33 Total Citation Count
- Sep 07, 1994 Earliest Filing
- 1 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0319,713 NOVEL METHOD FOR PRODUCING LIPOPLEX FOR TOPICAL ADMINISTRATION AND ANTITUMOR AGENT USING SUCH LIPOPLEXOct 28, 15Nov 09, 17[A61K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9855345 Method for producing lipoplex for topical administration and antitumor agent using such lipoplexOct 28, 15Jan 02, 18[A61K]
8592572 Liposome containing shRNA molecule targeting a thymidylate synthase and use thereofAug 22, 12Nov 26, 13[C07H]
8524876 RNAi molecule targeting thymidylate synthase and application thereofMar 29, 10Sep 03, 13[C07H]
8377905 Stable crystal of 1-(2′-cyano-2′-deoxy-β-D-arabinofuranosyl)cytosine monohydrochlorideMay 14, 10Feb 19, 13[A61K, C07H, A01N]
7863255 Methods of administering antitumor agent comprising deoxycytidine derivativeApr 29, 08Jan 04, 11[A61K, A01N]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2012/0301,537 LIPOSOME CONTAINING shRNA MOLECULE TARGETING A THYMIDYLATE SYNTHASE AND USE THEREOFAbandonedOct 14, 11Nov 29, 12[A61K, A61P]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.